1. Home
  2. RYI vs PCRX Comparison

RYI vs PCRX Comparison

Compare RYI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYI
  • PCRX
  • Stock Information
  • Founded
  • RYI 1842
  • PCRX 2006
  • Country
  • RYI United States
  • PCRX United States
  • Employees
  • RYI N/A
  • PCRX N/A
  • Industry
  • RYI Metal Fabrications
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYI Industrials
  • PCRX Health Care
  • Exchange
  • RYI Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • RYI 661.1M
  • PCRX 1.2B
  • IPO Year
  • RYI N/A
  • PCRX 2011
  • Fundamental
  • Price
  • RYI $22.52
  • PCRX $26.88
  • Analyst Decision
  • RYI Hold
  • PCRX Buy
  • Analyst Count
  • RYI 1
  • PCRX 10
  • Target Price
  • RYI $28.00
  • PCRX $29.30
  • AVG Volume (30 Days)
  • RYI 279.1K
  • PCRX 892.8K
  • Earning Date
  • RYI 02-20-2025
  • PCRX 02-27-2025
  • Dividend Yield
  • RYI 3.42%
  • PCRX N/A
  • EPS Growth
  • RYI N/A
  • PCRX N/A
  • EPS
  • RYI 0.64
  • PCRX N/A
  • Revenue
  • RYI $4,703,700,000.00
  • PCRX $694,957,000.00
  • Revenue This Year
  • RYI N/A
  • PCRX $5.14
  • Revenue Next Year
  • RYI $1.76
  • PCRX $2.44
  • P/E Ratio
  • RYI $33.54
  • PCRX N/A
  • Revenue Growth
  • RYI N/A
  • PCRX 4.40
  • 52 Week Low
  • RYI $17.18
  • PCRX $11.16
  • 52 Week High
  • RYI $36.15
  • PCRX $31.67
  • Technical
  • Relative Strength Index (RSI)
  • RYI 58.61
  • PCRX 77.75
  • Support Level
  • RYI $20.99
  • PCRX $25.06
  • Resistance Level
  • RYI $23.50
  • PCRX $27.10
  • Average True Range (ATR)
  • RYI 0.83
  • PCRX 1.45
  • MACD
  • RYI 0.24
  • PCRX 0.28
  • Stochastic Oscillator
  • RYI 67.92
  • PCRX 86.23

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority is from the United States.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: